Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariarosaria Conte

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Molecular pathways: the complexity of the epigenome in cancer and recent clinical advancesMariarosaria Conte, Lucia Altucci
Cancer Treatment and Research|October 12, 2013
Functions, aberrations, and advances for chromatin modulation in cancerMariarosaria Conte, Lucia Altucci
Antioxidants & Redox Signaling|January 3, 2014
Targeting Histone Deacetylases in Diseases: Where Are We?Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Marine Drugs|January 20, 2023
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New TargetsGiovanna Santaniello, Angela Nebbioso, Lucia Altucci, et al.
Marine Drugs|January 5, 2021
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer TherapyMariarosaria Conte, Elisabetta Fontana, Angela Nebbioso, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
FEBS Letters|June 30, 2019
HDAC2-dependent miRNA signature in acute myeloid leukemiaMariarosaria Conte, Carmela Dell'Aversana, Giulia Sgueglia, et al.
Frontiers in Chemistry|October 22, 2020
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical ResearchRosaria Benedetti, Mariarosaria Conte, Carmela Dell'Aversana, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Molecular pathways: the complexity of the epigenome in cancer and recent clinical advancesMariarosaria Conte, Lucia Altucci
Cancer Treatment and Research|October 12, 2013
Functions, aberrations, and advances for chromatin modulation in cancerMariarosaria Conte, Lucia Altucci
Antioxidants & Redox Signaling|January 3, 2014
Targeting Histone Deacetylases in Diseases: Where Are We?Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Marine Drugs|January 20, 2023
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New TargetsGiovanna Santaniello, Angela Nebbioso, Lucia Altucci, et al.
Marine Drugs|January 5, 2021
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer TherapyMariarosaria Conte, Elisabetta Fontana, Angela Nebbioso, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
FEBS Letters|June 30, 2019
HDAC2-dependent miRNA signature in acute myeloid leukemiaMariarosaria Conte, Carmela Dell'Aversana, Giulia Sgueglia, et al.
Frontiers in Chemistry|October 22, 2020
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical ResearchRosaria Benedetti, Mariarosaria Conte, Carmela Dell'Aversana, et al.
Pageof 7